חזרה לתוצאות החיפוש

Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Non-Hodgkin's Lymphoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

  • Beijing Boren Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Kai Hu, Dr.)

  • Beijing Cancer Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Yuqin Song, Dr.)

  • Peking University Third Hospital, Beijing, Beijing Municipality, China

    Contact: Study coordinator (Hongmei Jing, Dr.)

  • The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality, China

    Contact: Study coordinator (Lin Liu, Dr.)

  • Xinqiao Hospital of TMMU, Chongqing, Chongqing Municipality, China

    Contact: Study coordinator (Li Gao, Dr.)

  • Guangdong Provincial Peoples' Hospital, Guangzhou, Guangdong, China

    Contact: Study coordinator (Wenyu Li, Dr.)

  • SunYat-Sen University Cancer Center, Guangzhou, Guangdong, China

    Contact: Study coordinator (Huiqing Huang, Dr.)

  • Henan Cancer Hospital, Zhengzhou, Henan, China

    Contact: Study coordinator (Keshu Zhou, Dr.)

  • The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China

    Contact: Study coordinator (Mingzhi Zhang, Dr.)

  • Tongji Hospital, Tongji Medical College of HUST, Wuhan, Hubei, China

    Contact: Study coordinator (Liang Huang, Dr.)

  • Qilu Hospital of Shandong University, Jinan, Shandong, China

    Contact: Study coordinator (Chunyan Ji, Dr.)

  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Weili Zhao, Dr.)

  • Tongji Hospital of Tongji University, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Aibin Liang, Dr.)

  • West China Hospital，Sichuan University, Chengdu, Sichuan, China

    Contact: Study coordinator (Ting Niu, Dr.)

  • Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Dehui Zou, Dr.)

  • Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin Municipality, China

    Contact: Study coordinator (Lanfang Li, Dr.)

  • The First Affiliated Hospital, Zhejiang University school of Medicine, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Jie Jin, Dr.)
מובילי המחקר

  • Dehui Zou, Dr.

    Principal Investigator

    Institute of Hematology & Blood Diseases Hospital, China

  • Weili Zhao, Dr.

    Principal Investigator

    Ruijin Hospital

צפייה במקור ב־ClinicalTrials.gov(נפתח בחלון חדש)